Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 7 June 2014, Vol 292, No 7813

Sort by: Newest first Oldest first A-Z Z-A

  • Jonathan Burton

    Appraisal at a senior level Subscription

    4 JUN 2014 0:00 By Jeff Mills

    Jonathan Burton tells Jeff Mills how he is sharing his experience of RPS Faculty assessment with his pharmacy employees

  • A weighty problem

    4 JUN 2014 0:00

    New figures published in The Lancet last week show that the proportion of adults in the world who are overweight or obese increased between 1980 and 2013 from 29% to 37% in men and from 30% to 38% in women. Similarly, data from the Organisation for Economic Co-operation and Development suggest that most people in the world’s most developed nations and emerging economies are overweight or obese.

  • Mental health Subscription

    4 JUN 2014 0:00

    A new website, www.headmeds.org.uk, has launched to support young people aged 13–25 who take medicines for mental health conditions. The website contains information about potential side effects, frequently asked questions and case studies.

  • Parkinson’s disease Subscription

    4 JUN 2014 0:00

    Parkinson’s UK has launched a booklet with information for community pharmacists and their teams about how to help someone with Parkinson’s disease take control of their condition by effectively managing their medicines. The booklet is available from the Parkinson’s UK website.

  • Lenalidomide Subscription

    4 JUN 2014 0:00

    The National Institute for Health and Care Excellence has issued draft guidance that does not recommend lenalidomide (Revlimid; Celgene) for treating low- or intermiediate-1-risk myelodysplastic syndromes associated with a deletion 5q cytogenic abnormality when other therapeutic options are insufficient or inaccurate. The guidance is available for comment on the NICE website until 11 June 2014.  

  • RPS Faculty Subscription

    4 JUN 2014 0:00

    The Royal Pharmaceutical Society Faculty team is conducting three webinars to guide people through the Faculty journey and prepare them for the next submission date.

  • Dosing and compliance Subscription

    4 JUN 2014 0:00 By Michael Charvonia

    There appears to be a contradiction in the opening and closing paragraphs of Stuart Hill’s letter. In the first paragraph he criticises concerns over comparative potencies of corticosteroids as being “theoretical” and not evidence based but, in his final sentence, he suggests that once-daily dosing will improve compliance.

  • Opportunities to promote self care Subscription

    We welcome the article by Amisha Patel and Hemant Patel (PJ 2014;292:484), which focuses on self care of long-term conditions, how healthcare professionals should engage with it and the role community pharmacy should have in promoting this.

  • Deborah Evans

    National pharmacy board election results announced

    3 JUN 2014 0:00
    Comments (4)

    Deborah Evans joins the English Pharmacy Board and replaces Steve Hadley

  • Nurse on the telephone

    NHS England assures future of specialist pharmacy services

    2 JUN 2014 16:19

    Specialist pharmacy services are currently supported by the Department of Health, but this will now become the responsibility of NHS England until at least April 2016

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.